These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9214706

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis of novel succinamide derivatives having a 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. II.
    Watanabe T, Kakefuda A, Kinoyama I, Takizawa K, Hirano S, Shibata H, Yanagisawa I.
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1458-69. PubMed ID: 9331998
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T, Kakefuda A, Tanaka A, Takizawa K, Hirano S, Shibata H, Yamagiwa Y, Yanagisawa I.
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):53-68. PubMed ID: 9468637
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of 1,2,3,4-tetrahydroisoquinoline derivatives as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T, Kinoyama I, Takizawa K, Hirano S, Shibanuma T.
    Chem Pharm Bull (Tokyo); 1999 May; 47(5):672-7. PubMed ID: 10361700
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.
    Minarini A, Bolognesi ML, Budriesi R, Canossa M, Chiarini A, Spampinato S, Melchiorre C.
    J Med Chem; 1994 Sep 30; 37(20):3363-72. PubMed ID: 7932564
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramine.
    Angeli P, Cantalamessa F, Gulini U, Melchiorre C.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep 30; 352(3):304-7. PubMed ID: 8584046
    [Abstract] [Full Text] [Related]

  • 8. Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonist.
    Doods H, Entzeroth M, Ziegler H, Schiavi G, Engel W, Mihm G, Rudolf K, Eberlein W.
    Eur J Pharmacol; 1993 Sep 21; 242(1):23-30. PubMed ID: 8223934
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and biological activity of some methoctramine-related tetraamines bearing a 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepin-6-one moiety as antimuscarinics: a second generation of highly selective M2 muscarinic receptor antagonists.
    Melchiorre C, Bolognesi ML, Chiarini A, Minarini A, Spampinato S.
    J Med Chem; 1993 Nov 12; 36(23):3734-7. PubMed ID: 8246244
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
    Gillberg PG, Sundquist S, Nilvebrant L.
    Eur J Pharmacol; 1998 May 22; 349(2-3):285-92. PubMed ID: 9671109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones.
    Cohen VI, Jin B, McRee RC, Boulay SF, Cohen EI, Sood VK, Zeeberg BR, Reba RC.
    Brain Res; 2000 Apr 10; 861(2):305-15. PubMed ID: 10760492
    [Abstract] [Full Text] [Related]

  • 20. Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors.
    Novelli F, Sparatore A, Tasso B, Sparatore F.
    Bioorg Med Chem Lett; 1999 Oct 18; 9(20):3031-4. PubMed ID: 10571170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.